Table 1.
An overview of the distribution of participants according to clinical profile study (n = 250)
| Frequency | Percent | |
|---|---|---|
| Age group in years | ||
| 21–30 | 10 | 4.0 |
| 31–40 | 56 | 22.4 |
| 41–50 | 87 | 34.8 |
| 51–60 | 48 | 19.2 |
| 61–70 | 34 | 13.6 |
| 71–80 | 15 | 6.0 |
| Gender | ||
| Male | 144 | 57.6 |
| Female | 106 | 42.4 |
| Risk factors | ||
| None | 44 | 17.6 |
| Health care worker | 67 | 26.8 |
| Close contact with positive case | 88 | 35.2 |
| Travel history | 51 | 20.4 |
| Onset of anosmia | ||
| Before ENT symptoms | 44 | 17.6 |
| After ENT symptoms | 77 | 30.8 |
| At the same time | 58 | 23.2 |
| No symptoms | 65 | 26.0 |
| Cough | 108 | 43.2 |
| Fever | 73 | 29.2 |
| Sore throat | 45 | 18.0 |
| Shortness of breath | 25 | 10.0 |
| Headache | 124 | 49.6 |
| Nasal congestion | 58 | 23.2 |
| Rhinorrhoea | 15 | 6.0 |
| Asthenia | 133 | 52.8 |
| Myalgia | 98 | 39.6 |
| Nausea/vomiting | 23 | 7.6 |
| Diarrhoea | 30 | 10.4 |
| Addiction | ||
| Non-smoker | 127 | 50.8% |
| Mild smoker | 74 | 29.6% |
| Moderate smoker | 42 | 16.8% |
| Heavy smoker | 7 | 2.8% |
| Co-morbidities | ||
| None | 65 | 26.0 |
| Type 2 diabetes | 15 | 6.0 |
| HTN | 39 | 15.6 |
| Chronic rhinosinusitis | 26 | 10.4 |
| Allergic rhinitis | 47 | 18.8 |
| Asthma | 23 | 9.2 |
| Respiratory complaints | 17 | 6.8 |
| Hepatic dysfunctions | 5 | 2.0 |
| Renal dysfunction | 6 | 2.4 |
| CVS dysfunction | 3 | 1.2 |
| Others | 4 | 1.6 |
| Gustatory dysfunction | ||
| Not present | 52 | 20.8 |
| Patient not aware | 26 | 10.4 |
| Reduced ability to taste | 79 | 31.6 |
| Distorted taste perception | 93 | 37.2 |
| Recovery time of olfaction | ||
| 1–4 days | 17 | 6.8 |
| 5–8 days | 87 | 34.8 |
| 9–14 days | 103 | 41.2 |
| > 15 days | 43 | 17.2 |